GemVax&KAEL Co.,Ltd. (KOSDAQ: 082270)
South Korea
· Delayed Price · Currency is KRW
12,080
-540 (-4.28%)
Nov 15, 2024, 9:00 AM KST
GemVax&KAEL Co.,Ltd. Revenue
GemVax&KAEL Co.,Ltd. had revenue of 16.95B KRW in the quarter ending June 30, 2024, a decrease of -31.20%. This brings the company's revenue in the last twelve months to 63.58B, down -15.37% year-over-year. In the year 2023, GemVax&KAEL Co.,Ltd. had annual revenue of 72.21B, down -4.74%.
Revenue (ttm)
63.58B
Revenue Growth
-15.37%
P/S Ratio
7.70
Revenue / Employee
324.37M
Employees
196
Market Cap
492.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 72.21B | -3.60B | -4.74% |
Dec 31, 2022 | 75.80B | 15.43B | 25.56% |
Dec 31, 2021 | 60.37B | -5.29B | -8.06% |
Dec 31, 2020 | 65.66B | 23.00B | 53.91% |
Dec 31, 2019 | 42.66B | -4.58B | -9.69% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition